Ischemic Preconditioning-Like Effect of Polyunsaturated Fatty Acid-Rich Diet on Hepatic Ischemia/Reperfusion Injury

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Citação
JOURNAL OF GASTROINTESTINAL SURGERY, v.15, n.10, p.1679-1688, 2011
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Aim The aim of this study was to investigate a possible preconditioning effect of oral diet enriched with polyunsaturated fatty acids (PUFAs) on liver ischemia/reperfusion (I/R) injuries. Methods Wistar male rats were fed a standard diet or polyunsaturated fatty acid-rich diet (PRD) enriched with (GII) or without (GIII) omega-3 PUFA. Rats were submitted to partial liver ischemia during 1 h and evaluated in pre- and post-I/R conditions. In pre-I/R condition, livers were collected for determination of fatty acid composition, liver mitochondrial function, malondialdehyde (MDA) content, and histological analysis. Four hours after liver reperfusion serum activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), serum levels of tumor necrosis factor-alpha, interleukin-6, interleukin-10, and prostaglandin-E2, liver mitochondrial function, MDA content, and histology were evaluated. Results In the pre-I/R condition, GII and GIII groups had an increase on PUFA content and exhibited slight increased macrosteatosis and microsteatosis in the liver. After 4 h of reperfusion, PRD-fed rats showed a marked decrease on steatosis, diminished necrosis, an increase in MDA formation, and mitochondrial uncoupling. We also observed a marked decrease in plasma levels of cytokines and ALT and AST activities in post-I/R condition in PRD groups. Conclusion In this experimental model in the rat, PRD has a preconditioning effect protecting the liver from I/R injury and should be object of future clinical studies.
Palavras-chave
Liver ischemic/reperfusion lesion, Preconditioning, Polyunsaturated fatty acid-rich diet, Hepatic mitochondrial dysfunction
Referências
  1. Ambros JT, 2007, TRANSPLANT INT, V20, P219, DOI 10.1111/j.1432-2277.2006.00418.x
  2. Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010
  3. Ravati A, 2001, J NEUROCHEM, V78, P909, DOI 10.1046/j.1471-4159.2001.00463.x
  4. Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300
  5. El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625
  6. Montalvo-Jave EE, 2009, J GASTROINTEST SURG, V13, P2074, DOI 10.1007/s11605-009-0878-7
  7. Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933
  8. Trevisani F, 2002, DIGEST LIVER DIS, V34, P279, DOI 10.1016/S1590-8658(02)80148-7
  9. Figueira ERR, 2010, SURGERY, V147, P415, DOI 10.1016/j.surg.2009.10.018
  10. MURRY CE, 1986, CIRCULATION, V74, P1124
  11. CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0
  12. FOLCH J, 1957, J BIOL CHEM, V226, P497
  13. Sadeghi S, 1999, IMMUNOLOGY, V96, P404, DOI 10.1046/j.1365-2567.1999.00701.x
  14. Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137
  15. Quireze C, 2006, J INVEST SURG, V19, P229, DOI 10.1080/08941930600778206
  16. Montalvo-Jave EE, 2008, J SURG RES, V147, P153, DOI 10.1016/j.jss.2007.06.015
  17. Ravati A, 2000, BRAIN RES, V866, P23, DOI 10.1016/S0006-8993(00)02210-1
  18. Dirnagl U, 2008, NEUROPHARMACOLOGY, V55, P334, DOI 10.1016/j.neuropharm.2008.02.017
  19. Yoshizumi T, 1998, BRIT J SURG, V85, P1636
  20. Jassem W, 2002, TRANSPLANTATION, V73, P493, DOI 10.1097/00007890-200202270-00001
  21. ABUSHUFA R, 1994, CLIN CHEM, V40, P1707
  22. Simerabet M, 2008, BRAIN RES, V1240, P177, DOI 10.1016/j.brainres.2008.08.070
  23. LOWRY OH, 1951, J BIOL CHEM, V193, P265
  24. Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008
  25. Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323
  26. Frongillo F, 2009, TRANSPL P, V41, P1268, DOI 10.1016/j.transproceed.2009.03.096
  27. COELHO AM, 1977, BRAZ J MED BIOL RES, V30, P947
  28. Correia SC, 2010, J ALZHEIMERS DIS, V20, pS475, DOI 10.3233/JAD-2010-100669
  29. Cortez-Pinto H, 1999, GASTROENTEROLOGY, V116, P1184, DOI 10.1016/S0016-5085(99)70022-3
  30. ESTABROOK RW, 1967, METHOD ENZYMOL, P41
  31. HUGUET C, 1992, AM J SURG, V163, P602, DOI 10.1016/0002-9610(92)90567-B
  32. *I LAB AN RES COMM, 1996, GUID CAR US LAB AN
  33. Iwasaki W, 2010, SHOCK, V33, P306, DOI 10.1097/SHK.0b013e3181b2ffd2
  34. Iwata K, 1999, J GASTROEN HEPATOL, V14, P634, DOI 10.1046/j.1440-1746.1999.01929.x
  35. JANOFF A, 1964, Int Anesthesiol Clin, V2, P251, DOI 10.1097/00004311-196402000-00008
  36. KIM YI, 1994, TRANSPLANTATION, V58, P875, DOI 10.1097/00007890-199410270-00002
  37. LANG G, 1974, METHODS ENZYMATIC AN
  38. Matsuo K, 2005, J GASTROINTEST SURG, V9, P758, DOI 10.1016/j.gassur.2005.02.004
  39. Natori S, 1997, TRANSPLANTATION, V64, P1514, DOI 10.1097/00007890-199712150-00002
  40. Nilsson B, 2000, J GASTROINTEST SURG, V4, P44, DOI 10.1016/S1091-255X(00)80031-1
  41. Powner David J, 2004, Prog Transplant, V14, P241
  42. Selzner M, 2007, LIVER TRANSPLANT, V13, P382, DOI 10.1002/lt.21100
  43. Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0
  44. Tang LJ, 2007, WORLD J SURG, V31, P2039, DOI 10.1007/s00268-007-9186-0
  45. ZHONG Z, 1995, HEPATOLOGY, V22, P929, DOI 10.1016/0270-9139(95)90317-8